The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2019Immune Cell Dysfunction in PINK1 Parkinson’s Models
Promising Outcomes of Original Grant:
In our previous project, we significantly advanced the characterization of PINK1 knockout (KO) models. We found evidence of innate and adaptive immune cell... -
Research Grant, 2019Restoring the Nigrostriatal Pathway with Living Micto-tissue Engineered Axonal Tracts Supplement
Promising Outcomes of Original Grant:
The classic motor deficits of Parkinson’s disease (PD) are caused by degeneration of dopamine neurons, resulting in the loss of part of the neurons called axonal... -
Research Grant, 2019Developing New 18F-based Brain Tracers for Imaging Synapse in the Human Brain
Study Rationale:
A synapse is a structure that allow nerve cells (neurons) to communicate with one another or with target cells. In the brain, changes in synaptic density are associated with a variety... -
Parkinson's Global Genetics Discovery, 2019Genome-wide Association Study in Parkinson’s Disease Among an East Asian Population
Study Rationale:
The majority of the genome-wide association studies in Parkinson’s disease have included European ancestry cases and controls only, and targeted studies in East Asian populations only... -
Research Grant, 2019Astrocyte Activation as a Novel Marker of Disease Progression in Parkinson’s Disease: A PET Imaging Study
Study Rationale:
Brain inflammation, regulated by cells called microglia and astrocytes, has been shown to play a role in the initiation and progression of Parkinson’s disease. However, the role of... -
LRRK2 Biology Consortium, 2019LRRK2 Activity and Dyskinesia Supplement
Promising Outcomes of Original Grant:
Our preliminary funding supported exploration of the role of striatal LRRK2 in the development of levodopa-induced dyskinesia (LID). We found that inhibiting...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.